✦ LIBER ✦

P.3.c.073 Cabergoline in the management of prolactine-induced symptoms in patients treated with atypical neuroleptics

✍ Scribed by J. Cobo; R. Coronas; O. Jiménez-Palop; M. Pérez; R. Mas; L. Ros; G. García-Parés

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.c.010 Severity of negative symptoms

✍ M. Krzystanek; E. Krzystanek; I. Krupka-Matuszczyk 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 103 KB

P.3.004 Use of the dopamine agonist cabe

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 110 KB

P.3.c.002 Prevalence of lower urinary tr

✍ I.W. Chung; S.H. Jeong 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

P.3.c.073 Relation of the change in symp

✍ I. Yildiz; A. Ertugrul; C. Temucin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 185 KB

P.3.c.039 Audit of extrapyramidal sympto

✍ A. Khan; S. Mustafa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 187 KB

P.3.c.023 Glycine plasma levels are not

✍ D. Strzelecki; J. Rabe-Jablonska 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB